<feed xmlns="http://www.w3.org/2005/Atom" xml:base="http://www.healthnewswire.net/">
	<title type="text">Latest Health research news from the around the globe</title>
	<id>http://www.healthnewswire.net/</id>
	<link rel="alternate" type="text/html" hreflang="en" href="index.php" />
	<link rel="self" type="application/atom+xml" href="http://www.healthnewswire.net/medical_technology/index.1.atom" />
	<rights>&amp;copy;2007 Spoonlabs d.o.o.</rights>
	<generator>Vivvo CMS 4.0</generator>
	<updated>2012-02-07T17:21:06+00:00</updated>
	
			
				
					<entry>
						<title>St. Jude Medical to Showcase Complete Cardiovascular Access, Intervention and Hemostasis Management Solutions at Transcatheter Cardiovascular Therapeutics (TCT) </title>
						<id>http://www.healthnewswire.net/medical_technology/1085.html</id>
						<link rel="alternate" type="text/html" hreflang="en" href="http://www.healthnewswire.net/medical_technology/1085.html" />
						<published>2009-09-23T14:45:00+00:00</published>
						<updated>2009-09-23T14:45:00+00:00</updated>
						<author>
							<name>admin</name>
						</author>
						<category term="tech" scheme="http://www.healthnewswire.net/medical_technology/1085.html" label="tech" />
						<content type="html">St. Jude Medical, Inc. (NYSE:STJ) today announced it will display products and technologies from the company&amp;#039;s portfolio of solutions for cardiovascular healthcare professionals at the 21st annual Transcatheter Cardiovascular Therapeutics meeting in San Francisco. The featured products reflect the company&amp;#039;s continued commitment to developing comprehensive, high-performance solutions which advance the practice of interventional cardiology by improving efficiencies and giving physicians more control. </content>
					</entry>
				
					<entry>
						<title>FDA Awards Three Grants Designed to Stimulate Development of Pediatric Medical Devices</title>
						<id>http://www.healthnewswire.net/medical_technology/1077.html</id>
						<link rel="alternate" type="text/html" hreflang="en" href="http://www.healthnewswire.net/medical_technology/1077.html" />
						<published>2009-09-22T05:10:00+00:00</published>
						<updated>2009-09-22T05:10:00+00:00</updated>
						<author>
							<name>admin</name>
						</author>
						<category term="tech" scheme="http://www.healthnewswire.net/medical_technology/1077.html" label="tech" />
						<content type="html">Awardees will work with industry and the FDA to address unmet pediatric device needs
</content>
					</entry>
				
					<entry>
						<title>St. Jude Medical Announces FDA Approval of EnSite Velocity Cardiac Mapping System</title>
						<id>http://www.healthnewswire.net/medical_technology/1028.html</id>
						<link rel="alternate" type="text/html" hreflang="en" href="http://www.healthnewswire.net/medical_technology/1028.html" />
						<published>2009-09-14T14:40:00+00:00</published>
						<updated>2009-09-14T14:40:00+00:00</updated>
						<author>
							<name>admin</name>
						</author>
						<category term="tech" scheme="http://www.healthnewswire.net/medical_technology/1028.html" label="tech" />
						<content type="html">Next-generation cardiac mapping system gives physicians the ability to increase procedural efficiency and speed for treating irregular heart rhythms
</content>
					</entry>
				
					<entry>
						<title>St. Jude Medical Receives CE Mark Approval for World&#039;s Smallest, Longest-Lasting Rechargeable Deep Brain Stimulator for Parkinson&#039;s Disease  First patient implanted with Brio neurostimulator at University of Cologne, Germany </title>
						<id>http://www.healthnewswire.net/medical_technology/1010.html</id>
						<link rel="alternate" type="text/html" hreflang="en" href="http://www.healthnewswire.net/medical_technology/1010.html" />
						<published>2009-09-10T15:25:00+00:00</published>
						<updated>2009-09-10T15:25:00+00:00</updated>
						<author>
							<name>admin</name>
						</author>
						<category term="tech" scheme="http://www.healthnewswire.net/medical_technology/1010.html" label="tech" />
						<content type="html"> First patient implanted with Brio neurostimulator at University of Cologne, Germany  </content>
					</entry>
				
					<entry>
						<title>Abbott Launches Next-Generation XIENCE PRIME™ Drug Eluting Stent in International Markets </title>
						<id>http://www.healthnewswire.net/medical_technology/964.html</id>
						<link rel="alternate" type="text/html" hreflang="en" href="http://www.healthnewswire.net/medical_technology/964.html" />
						<published>2009-09-01T14:32:00+00:00</published>
						<updated>2009-09-01T14:32:00+00:00</updated>
						<author>
							<name>admin</name>
						</author>
						<category term="tech" scheme="http://www.healthnewswire.net/medical_technology/964.html" label="tech" />
						<content type="html">—New Cobalt Chromium Stent Offers Enhanced Deliverability with a Broad Matrix of Sizes
—Built Upon the Proven Track Record of Superior Clinical Outcomes of Abbott&amp;#039;s Market-Leading XIENCE V® Drug Eluting Stent
</content>
					</entry>
				
					<entry>
						<title>Infectious Disease and Bioterrorism: A New Model for Protection</title>
						<id>http://www.healthnewswire.net/medical_technology/961.html</id>
						<link rel="alternate" type="text/html" hreflang="en" href="http://www.healthnewswire.net/medical_technology/961.html" />
						<published>2009-08-26T12:42:00+00:00</published>
						<updated>2009-08-26T12:42:00+00:00</updated>
						<author>
							<name>admin</name>
						</author>
						<category term="tech" scheme="http://www.healthnewswire.net/medical_technology/961.html" label="tech" />
						<content type="html">UPMC and University of Pittsburgh leaders today proposed an innovative solution to the country’s pressing need to improve its vaccine-producing abilities. As recent events have shown, the spread of infectious diseases poses an ever-increasing threat to the U.S., and nearly every western government recognizes the need to strengthen its response against a bioterrorist attack.
</content>
					</entry>
				
					<entry>
						<title>FDA Enhances Speed and Transparency of Actions Taken Against Misconduct in Drug and Device Development </title>
						<id>http://www.healthnewswire.net/medical_technology/807.html</id>
						<link rel="alternate" type="text/html" hreflang="en" href="http://www.healthnewswire.net/medical_technology/807.html" />
						<published>2009-08-08T01:48:00+00:00</published>
						<updated>2009-08-08T01:48:00+00:00</updated>
						<author>
							<name>admin</name>
						</author>
						<category term="tech" scheme="http://www.healthnewswire.net/medical_technology/807.html" label="tech" />
						<content type="html">The U.S. Food and Drug Administration today announced it has stepped up its efforts to prevent non-compliant investigators and others from participating in new product development. </content>
					</entry>
				
					<entry>
						<title>Hearing impaired get better hearing with cochlear implant plus hearing aid </title>
						<id>http://www.healthnewswire.net/medical_technology/786.html</id>
						<link rel="alternate" type="text/html" hreflang="en" href="http://www.healthnewswire.net/medical_technology/786.html" />
						<published>2009-08-06T02:03:00+00:00</published>
						<updated>2009-08-06T02:03:00+00:00</updated>
						<author>
							<name>admin</name>
						</author>
						<category term="tech" scheme="http://www.healthnewswire.net/medical_technology/786.html" label="tech" />
						<content type="html">By Gwen Ericson -- Adults with severe hearing loss benefit from pairing a cochlear implant in one ear with a hearing aid in the other ear, even though the sound signals from each device are very different, according to a study at Washington University School of Medicine in St. Louis published in the June issue of the Journal of the American Academy of Audiology. </content>
					</entry>
				
					<entry>
						<title>Researchers Effectively Treat Tumors with Use of Nanotubes  </title>
						<id>http://www.healthnewswire.net/medical_technology/756.html</id>
						<link rel="alternate" type="text/html" hreflang="en" href="http://www.healthnewswire.net/medical_technology/756.html" />
						<published>2009-08-03T14:52:00+00:00</published>
						<updated>2009-08-03T14:52:00+00:00</updated>
						<author>
							<name>admin</name>
						</author>
						<category term="tech" scheme="http://www.healthnewswire.net/medical_technology/756.html" label="tech" />
						<content type="html">WINSTON-SALEM, N.C. – By injecting man-made, microscopic tubes into tumors and heating them with a quick, 30-second zap of a laser, scientists have discovered a way to effectively kill kidney tumors in nearly 80 percent of mice. Researchers say that the finding suggests a potential future cancer treatment for humans.</content>
					</entry>
				
					<entry>
						<title>Early Detection and Quick Response Are Key to Defense Against Anthrax Attack</title>
						<id>http://www.healthnewswire.net/medical_technology/706.html</id>
						<link rel="alternate" type="text/html" hreflang="en" href="http://www.healthnewswire.net/medical_technology/706.html" />
						<published>2009-07-27T15:29:00+00:00</published>
						<updated>2009-07-27T15:29:00+00:00</updated>
						<author>
							<name>admin</name>
						</author>
						<category term="tech" scheme="http://www.healthnewswire.net/medical_technology/706.html" label="tech" />
						<content type="html">Delays Could Overwhelm Hospitals, According to New Study by Weill Cornell Medical School Public Health Researchers</content>
					</entry>
				
			
		
</feed>
